Repligen Corporation (RGEN) Narrowly Beats Estimates, Posts Q2 3c Loss
Repligen Corporation (NASDAQ: RGEN) reports Q2 loss of $0.03, 1 cent better than the analyst estimate of ($0.04). Revenue for the quarter was $5.42 million, which compares to the estimate of $5.19 million.
Related Categories
EarningsStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
